Cambridge Investment Research Advisors »

Ascendis Pharma A S shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $209k 1.1k 199.05
2024-12-31 $689k 5.0k 137.61

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Lombard Odier Asset Management
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
T. Rowe Price Investment Management
Massachusetts Financial Services
Wellington Management Company
Franklin Resources
Perceptive Advisors
Invesco
Polar Capital Holdings

View all funds holding Ascendis Pharma A S